Oric PharmaceuticalsORIC
13F holders, Q3 2025 (September 30)152holders +10
32new positions
22sold out
6famous investors
$12.00avg. 13F price*
At the end of Q3 2025, 152 institutions reported holding Oric Pharmaceuticals Inc. (ORIC) in their 13F filings, up 10 from Q2 2025. 32 opened new positions and 22 sold out. The largest holders were Nextech Invest Ltd. ($86.0M), EcoR1 Capital, LLC ($80.7M) and Venrock Adviser, LLC ($79.2M). 6 famous investors held it, including Andreas Halvorsen (0.2% of Viking Global Investors's portfolio), Steve Cohen (0.1% of Point72 Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Oric Pharmaceuticals Inc.
- CUSIP
- 68622P109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 32 | $16.0M |
| Exits | 22 | $21.0M |
All 13F filers, Q2 2025 → Q3 2025: 17,809,814 shares bought and 4,681,293 shares sold, net +13,128,521 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 152 holders
| Nextech Invest Ltd. | 13.08% | No change | 7,162,637 | $86.0M |
| EcoR1 Capital, LLC | 3.88% | Add +315.8% | 6,728,116 | $80.7M |
| Venrock Adviser, LLC | 4.46% | No change | 6,596,885 | $79.2M |
| Viking Global Investors | 0.20% | No change | 6,572,700 | $78.9M |
| Pfizer Inc | 14.75% | No change | 5,376,344 | $64.5M |
| BlackRock, Inc. | 0.00% | Add +29.4% | 5,276,620 | $63.3M |
| Vanguard Group Inc. | 0.00% | Add +48.8% | 4,650,138 | $55.8M |
| SR One Capital Management, LP | 7.84% | No change | 4,514,929 | $54.2M |
| Alkeon Capital Management LLC | 0.24% | No change | 4,504,096 | $54.0M |
| NEA Management Company, LLC | 2.71% | No change | 4,118,621 | $49.4M |
| Orbimed Advisors LLC | 1.05% | Add +305.0% | 3,641,756 | $43.7M |
| Column Group LLC | 52.48% | No change | 3,540,777 | $42.5M |
| Vivo Capital, LLC | 3.02% | No change | 3,126,604 | $37.5M |
| T. Rowe Price Associates Inc. | 0.00% | Add +3.9% | 2,871,327 | $34.5M |
| Point72 Asset Management | 0.07% | Reduce -8.1% | 2,619,914 | $31.4M |
| FMR LLC | 0.00% | Add +2.4% | 2,528,048 | $30.3M |
| State Street Corp. | 0.00% | Add +47.3% | 2,403,939 | $28.8M |
| First Turn Management, LLC | 3.89% | Add +7.4% | 2,159,474 | $25.9M |
| Silverarc Capital Management, LLC | 3.39% | Add +8.2% | 1,948,808 | $23.4M |
| MPM Bioimpact LLC | 3.40% | No change | 1,729,378 | $20.8M |
| Geode Capital Management, LLC | 0.00% | Add +47.1% | 1,630,744 | $19.6M |
| Balyasny Asset Management L.P. | 0.04% | Reduce -14.5% | 1,519,314 | $18.2M |
| Royce & Associates LP | 0.17% | Add +521.2% | 1,458,483 | $17.5M |
| JPMorgan Chase & Co. | 0.00% | Reduce -8.0% | 1,228,528 | $14.7M |
| Citadel Advisors | 0.01% | Reduce -14.6% | 1,198,004 | $14.4M |
| Franklin Resources Inc. | 0.00% | Add +13.3% | 1,181,329 | $14.2M |
| ArrowMark Colorado Holdings LLC | 0.24% | Reduce -14.2% | 1,097,497 | $13.2M |
| Siren, L.L.C. | 0.47% | No change | 1,007,575 | $12.1M |
| Euclidean Capital LLC | 4.99% | No change | 989,410 | $11.9M |
| Eventide Asset Management, LLC | 0.19% | Add +0.0% | 951,507 | $11.4M |
| Goldman Sachs Group Inc. | 0.00% | Add +84.8% | 904,812 | $10.9M |
| Integral Health Asset Management, LLC | 0.79% | Reduce -28.0% | 900,000 | $10.8M |
| Northern Trust Corp. | 0.00% | Add +121.6% | 888,535 | $10.7M |
| Dimensional Fund Advisors LP | 0.00% | Add +11.1% | 793,871 | $9.5M |
| Morgan Stanley | 0.00% | Add +88.8% | 745,528 | $8.9M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +57.8% | 603,207 | $7.2M |
| Polar Capital Holdings Plc | 0.03% | New | 468,610 | $5.6M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | Add +22.4% | 447,366 | $5.4M |
| Sphera Funds Management LTD. | 1.23% | Add +9.4% | 431,693 | $5.2M |
| UBS Group AG | 0.00% | Add +242.6% | 339,236 | $4.1M |
| Sectoral Asset Management Inc. | 2.43% | Add +42.0% | 328,655 | $3.9M |
| Woodline Partners LP | 0.01% | Add +0.9% | 246,534 | $3.0M |
| BNP Paribas Financial Markets | 0.00% | Add +175.1% | 238,620 | $2.9M |
| Nicholas Investment Partners, LP | 0.23% | Add +197.3% | 220,735 | $2.6M |
| Barclays PLC | 0.00% | Add +29.0% | 184,091 | $2.2M |
| Bank of New York Mellon Corp | 0.00% | Add +30.1% | 175,714 | $2.1M |
| AQR Capital Management | 0.00% | Add +0.3% | 171,925 | $2.1M |
| Resolute Capital Asset Partners LLC | 1.05% | Reduce -26.4% | 167,515 | $2.0M |
| Stempoint Capital LP | 0.40% | Reduce -17.1% | 166,461 | $2.0M |
| TD Asset Management Inc | 0.00% | Reduce -14.6% | 151,700 | $1.8M |
| Wellington Management Group LLP | 0.00% | Reduce -32.6% | 150,594 | $1.8M |
| Driehaus Capital Management LLC | 0.01% | New | 148,778 | $1.8M |
| Hennion & Walsh Asset Management, Inc. | 0.06% | Reduce -1.8% | 147,048 | $1.8M |
| Atom Investors LP | 0.13% | Reduce -43.6% | 142,601 | $1.7M |
| Millennium Management | 0.00% | Reduce -59.9% | 140,433 | $1.7M |
| Nuveen, LLC | 0.00% | Add +12.2% | 137,692 | $1.7M |
| Victory Capital Management Inc. | 0.00% | Reduce -0.3% | 132,220 | $1.6M |
| American Century Companies Inc. | 0.00% | Add +43.2% | 130,576 | $1.6M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +2.1% | 126,664 | $1.5M |
| Exome Asset Management LLC | 0.96% | New | 120,644 | $1.4M |
| Boothbay Fund Management, LLC | 0.04% | New | 110,833 | $1.3M |
| DAFNA Capital Management LLC | 0.31% | Reduce -22.6% | 104,671 | $1.3M |
| Bank of America Corp. | 0.00% | Reduce -65.3% | 103,450 | $1.2M |
| Royal Bank of Canada | 0.00% | Reduce -3.4% | 96,549 | $1.2M |
| Invesco Ltd. | 0.00% | Add +48.8% | 91,614 | $1.1M |
| State of Wisconsin Investment Board | 0.00% | Add +246.9% | 89,753 | $1.1M |
| Superstring Capital Management LP | 1.06% | Reduce -74.1% | 89,346 | $1.1M |
| Rafferty Asset Management, LLC | 0.00% | Add +100.7% | 85,592 | $1.0M |
| Rhumbline Advisers | 0.00% | Add +14.8% | 82,031 | $984K |
| Swiss National Bank | 0.00% | New | 66,100 | $793K |
| Alliancebernstein L.P. | 0.00% | No change | 63,810 | $766K |
| Jane Street Group, LLC | 0.00% | Add +34.2% | 62,678 | $752K |
| Wells Fargo & Company | 0.00% | Add +51.7% | 50,963 | $612K |
| Caption Management, LLC | 0.04% | New | 49,389 | $593K |
| Brevan Howard Capital Management LP | 0.01% | Add +41.4% | 49,095 | $589K |
| New York State Common Retirement Fund | 0.00% | Add +153.4% | 45,077 | $541K |
| Palumbo Wealth Management LLC | 0.17% | Reduce -5.9% | 44,026 | $528K |
| Deutsche Bank AG | 0.00% | Add +10.2% | 42,497 | $510K |
| Optimize Financial Inc. | 0.24% | New | 39,044 | $469K |
| LMR Partners LLP | 0.01% | No change | 35,267 | $423K |
| MetLife Investment Management, LLC | 0.00% | Add +25.5% | 33,970 | $408K |
| Legal & General Group Plc | 0.00% | Add +663.5% | 33,126 | $398K |
| Prelude Capital Management, LLC | 0.03% | New | 33,037 | $396K |
| California State Teachers Retirement System | 0.00% | Add +1067.5% | 32,689 | $392K |
| Gsa Capital Partners LLP | 0.03% | New | 31,928 | $383K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +17.7% | 31,371 | $375K |
| Squarepoint Ops LLC | 0.00% | Reduce -71.2% | 30,733 | $369K |
| Dark Forest Capital Management LP | 0.01% | New | 29,851 | $358K |
| Susquehanna Portfolio Strategies, LLC | 0.01% | New | 27,524 | $330K |
| China Universal Asset Management Co., Ltd. | 0.03% | Add +89.3% | 27,024 | $324K |
| Susquehanna Fundamental Investments, LLC | 0.01% | Reduce -41.2% | 25,518 | $306K |
| Legato Capital Management LLC | 0.03% | New | 23,396 | $281K |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | New | 23,235 | $279K |
| Jasper Ridge Partners, L.P. | 0.01% | No change | 20,870 | $250K |
| Profund Advisors LLC | 0.01% | New | 18,720 | $225K |
| SG Americas Securities, LLC | 0.00% | New | 18,023 | $216K |
| Creative Planning | 0.00% | Add +59.5% | 17,694 | $212K |
| Intech Investment Management LLC | 0.00% | Reduce -31.7% | 17,383 | $209K |
| Fox Run Management, L.L.C. | 0.03% | New | 16,887 | $203K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | New | 16,437 | $197K |
"% of holder's portfolio" is ORIC's weight in each manager's 13F, not the share of Oric Pharmaceuticals Inc. the manager owns.